Larvol Delta - A-Phase-1b-Study-to-Investigate-Safety-and-Tolerability-of-ARGX119-in-Adult-Participants-With-DOK7Congenital-Myasthenic-Syndromes-CMS

adimanebart (ARGX-119) - argenx

http://clinicaltrials.gov/ct2/show/NCT06436742

Jul 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next